NDC Product
Human Prescription DrugHercessi NDC 69448-015
- Generic Name
- Trastuzumab-strf
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing
- BLA
Active Listing
TRASTUZUMAB
UNII P188ANX8CK
Substance Identification & Data
This profile provides standardized clinical and technical data for Trastuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P188ANX8CK.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 180288-69-1 and the RxNorm Concept ID (RxCUI) 224905. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Preferred Name
TRASTUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
P188ANX8CK
The specific atomic composition represented as a molecular structure string.
INN ID
7637
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
II-48
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Trastuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
TRASTUZUMAB
TRASTUZUMAB (HERCEPTIN)
TRASTUZUMAB BETA
TRASTUZUMAB-ANNS
TRASTUZUMAB-DKST
TRASTUZUMAB-DTTB
TRASTUZUMAB-OYSK
TRASTUZUMAB-PKRB
TRASTUZUMAB-QYYP
TRASTUZUMAB-STRF
TRASTUZUMAB-ZZXF
Common Names & Synonyms
ABP-980 (TRASTUZUMAB BIOSIMILAR)
CANHERA
DMB-3111
EG-12014 (TRASTUZUMAB BIOSIMILAR)
EG12014 TRASTUZUMAB BIOSIMILAR
HLX-02 TRASTUZUMAB BIOSIMILAR
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB HER2(SUB .GAMMA.1)-CHAIN ANTIHUMAN P185(SUP C-ERBB2) RECEPTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB HER2 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB HER2(SUB .GAMMA.1)-CHAIN ANTIHUMAN P185(SUP C-ERBB2) RECEPTOR), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB HER2 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL RHUMAB HER2(SUB .GAMMA.1)-CHAIN ANTIHUMAN P185(SUP C-ERBB2) RECEPTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB HER2 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL RHUMAB HER2(SUB .GAMMA.1)-CHAIN ANTIHUMAN P185(SUP C-ERBB2) RECEPTOR), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB HER2 LIGHT CHAIN, DIMER
PF-05280014
PF-05280014 (TRASTUZUMAB BIOSIMILAR)
SB-3
SB-3 (TRASTUZUMAB BIOSIMILAR)
TRASTUZUMAB [EMA EPAR]
TRASTUZUMAB [INN]
TRASTUZUMAB [JAN]
TRASTUZUMAB [MART.]
TRASTUZUMAB [MI]
TRASTUZUMAB [PURPLE BOOK CDER]
TRASTUZUMAB [USAN]
TRASTUZUMAB [VANDF]
TRASTUZUMAB [WHO-DD]
TRASTUZUMAB ANNS [WHO-DD]
TRASTUZUMAB BETA [INN]
TRASTUZUMAB BIOSIMILAR (ABP-980)
TRASTUZUMAB BIOSIMILAR (AMGEN)
TRASTUZUMAB BIOSIMILAR (CELLTRION)
TRASTUZUMAB BIOSIMILAR (CT-P6)
TRASTUZUMAB BIOSIMILAR (MYL-1401O)
TRASTUZUMAB BIOSIMILAR (MYLAN GMBH)
TRASTUZUMAB BIOSIMILAR (PFIZER)
TRASTUZUMAB BIOSIMILAR (SB-3)
TRASTUZUMAB DKST [WHO-DD]
TRASTUZUMAB DTTB [WHO-DD]
TRASTUZUMAB PKRB [WHO-DD]
TRASTUZUMAB QYYP [WHO-DD]
TRASTUZUMAB STRF [WHO-DD]
TRASTUZUMAB, LICENSE HOLDER UNSPECIFIED
TRASTUZUMAB-DKST [PURPLE BOOK CDER]
TRASTUZUMAB-DTTB [PURPLE BOOK CDER]
TRASTUZUMAB-PKRB [PURPLE BOOK CDER]
Brand / Trade Names
HERCEPTIN
HERCEPTIN HYLECTA COMPONENT TRASTUZUMAB
HERCESSI
HERZUMA
KANJINTI
OGIVRI
ONTRUZANT
PHESGO COMPONENT TRASTUZUMAB
TRAZIMERA
ZERCEPAC
Technical Codes
4D5V8
ABP980
ABP-980
BMAB-200
CTP6
CTP-6
CT-P6
DMB-3111 (TRASTUZUMAB BIOSIMILAR)
EG12014
EG-12014
HLX02
HLX-02
R-597
RHUMAB HER2
RHUMABHER2
RO0452317
RO-0452317
SYD977
SYD-977
NDC Products Containing TRASTUZUMAB
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
